Cathay Biotech Inc. (SHA:688065)
China flag China · Delayed Price · Currency is CNY
42.16
-1.30 (-2.99%)
May 25, 2026, 3:00 PM CST

Cathay Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
30,38335,88922,55532,01235,74976,786
Market Cap Growth
-20.68%59.12%-29.54%-10.45%-53.44%116.67%
Enterprise Value
25,68430,77922,81831,82333,87871,142
Last Close Price
42.1649.8038.4854.2660.32128.99
PE Ratio
51.1464.0146.1387.3464.61129.11
Forward PE
34.7729.6129.6146.7489.6189.61
PS Ratio
8.9510.897.6315.1414.6532.49
PB Ratio
1.411.681.492.172.385.23
P/TBV Ratio
1.772.122.083.063.527.77
P/OCF Ratio
102.7788.8127.4856.2244.48132.69
EV/Sales Ratio
7.579.347.7115.0513.8830.10
EV/EBITDA Ratio
24.3136.7631.8170.5250.43106.53
EV/EBIT Ratio
34.6658.4357.61192.2383.32142.50
Debt / Equity Ratio
0.050.020.130.120.080.05
Debt / EBITDA Ratio
1.210.602.653.941.681.11
Net Debt / Equity Ratio
-0.39-0.41-0.23-0.24-0.34-0.61
Net Debt / EBITDA Ratio
-9.21-10.45-4.81-8.01-7.69-13.31
Net Debt / FCF Ratio
17.9425.78154.133.611.5210.09
Asset Turnover
0.140.150.160.120.140.17
Inventory Turnover
1.831.761.601.011.171.56
Quick Ratio
4.264.871.991.704.758.14
Current Ratio
5.115.852.532.225.959.36
Return on Equity (ROE)
2.67%2.91%3.18%2.74%4.12%4.84%
Return on Assets (ROA)
1.51%1.54%1.31%0.56%1.49%2.20%
Return on Invested Capital (ROIC)
3.96%3.66%3.01%1.43%4.57%7.95%
Return on Capital Employed (ROCE)
2.70%2.40%2.50%1.10%2.50%3.30%
Earnings Yield
1.94%1.56%2.17%1.15%1.55%0.78%
FCF Yield
-1.53%-0.95%-0.10%-3.13%-9.50%-1.15%
Dividend Yield
1.04%0.90%1.04%0.35%0.30%0.25%
Payout Ratio
51.44%55.84%28.80%37.58%37.39%57.11%
Buyback Yield / Dilution
-22.28%-17.47%-0.05%0.10%0.11%-7.38%
Total Shareholder Return
-21.25%-16.57%0.99%0.45%0.41%-7.13%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.